An observational, retrospective study evaluated the efficacy and safety of Eslicarbazepine acetate in patients with focal epilepsies in daily clinical practice in Galicia, Spain
Latest Information Update: 04 Mar 2016
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- Acronyms ESLI-ATLANTICO
Most Recent Events
- 04 Mar 2016 New trial record